Eden Biodesign to offer Millipore Corporation’s Proprietary Expression Technology as part of its Cell Line Development Services and cGMP Manufacturing of Highly Productive Mammalian Cell Lines

LIVERPOOL, United Kingdom & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Eden Biodesign Ltd. and Millipore Corporation today announced a partnership that will provide biopharmaceutical companies with access to a powerful combination of Eden’s cGMP manufacturing and Millipore’s Ubiquitous Chromatin Opening Elements (UCOE®) expression technology.